Ingenia Ambition S - For use as a diagnostic device to obtain cross-sectional images, spectroscopic images and/or spe... — FDA record Z-3197-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 3, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Ingenia Ambition S - For use as a diagnostic device to obtain cross-sectional images, spectroscopic images and/or spectra of the internal structure of the head, body or extremities, in any orientation. (REF) Numbers: 1) 782108 2) 781359 3) 782133
Reason
Integrated Radio Frequency (IRF) Carrier assembly screws may come loose and protrude beyond the surface could cause the screws to interfere with other moving parts, potentially blocking the horizontal tabletop. May lead to delay in diagnosis and/or may include anxiety of a patient is left on the tabletop inside the bore for a longer duration than anticipated. movement.
Classification
Class II
Recalling firm
Philips North America Llc
Quantity
64 units
Agency-reported status
Ongoing
Source record identifier
Z-3197-2024

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityModel UDI-DI: 782108 (01)00884838098343(21); 781359 (01)00884838090057(21). 782133 N/A Serial Numbers: 27506 27508 27509 27512 27514 27515 27516 27517 27518 27519 27520 27523 27524 27525 27526 27528 27531 48146 48164 48550 48556 48588 48589 48608 48612 48627 48648 48661 48662 48663 48664 48665 48666 48667 48669 48672 48679 48686 48688 48694 48696 48697 48698 48699 48700 48707 48708 48710 48714 48715 48721 48725 48726 48728 48729 48738 48744 48749 48754 48800 48804 48810 48813 48833

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Finland, France, Germany, Iceland, India, Indonesia, Iran, Iraq, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Maldives, Mauritius, Mexico, Morocco, Netherlands, Pakistan, Peru, Poland, Portugal, Qatar, Romania, Russian Fed., Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Switzerland, Thailand, T¿rkiye, United Kingdom, Utd.Arab.Emir., Uzbekistan, Vietnam.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Oct 2, 2024
Recall initiation date
Sep 3, 2024
Center classification date
Sep 20, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records